Lepu Medical - MemoPart VSD Occluder

  Out-of-Stock 

Purchase at Moment

Payment After 3 Month

Quarterly repayment with the lowest fees Recharge every three months, 200 million tomman for each season.

Features:

VSD Occluder 

China Made

Nitinol Wire

 
Notify me when available

  • 0
  • Out stock
  • Free

Pay in installments

Choose your plan:

Current plan: 3Month

Description: 30+3

Down payment: تومان0 (25.00%)

Number of payments: 3

Tax: تومان0

Amount of payment: تومان0

Overpayment: تومان0

Total: تومان0

Current plan: Cash

Description: نقدی

Down payment: تومان0 (0.00%)

Number of payments: 1

Tax: تومان0

Amount of payment: تومان0

Overpayment: تومان0

Total: تومان0

Description

Optimal heart treatment on the Nitinol wire provides the occluder superior elasticity for easier delivery.

 

Rigidity

 

Modified rigidity and flexibility for different types of occluders are designed to meet different clinical requirements.

 

 

Structure

 

Special braided mesh structure provides excellent radial strength that ensures ideal configuration after deployment, allows of full cross-sectional orifice coverage, and minimizes operation risk.

 

Shape and Size

 

Complete range of occlude specifications can satisfy the most types and sizes of defects.

 

Heat–Treated Nitinol Wire

Special oxidization process makes the compact and uniform surface of TiO2 on the nitinol wire. The oxidation surface effectively prevents from the release of nickel ion to guarantees great biocompatibility and long-term safety.

 

 

Multiple Sizes of Waist Length for VSD Occluder

 

Instead of only one size of waist length, MemoPartTM VSD occluders provide 3-4 sizes of waist length to minimize the negative impact of compression force, which could highly reduce the risk of third degree atrioventricular block.

 

Transcatheter Closure of pmVSD by Using the Modified MemoPart Occluder 

 

This multicenter study assessed the efficacy and safety of transcatheter closure of perimembranous VSD using MemoPart VSD occluders. In 5 different centers in China, 412 patients with VSD, including 202 men and 210 women. The immediate success rate was 96.6%. During the follow-up period of 2 years, there was no evidence of residual shunt and device-related complications.

 



Reference : 0

Data sheet

  • China

Specific References

New product



Leave a comment about this product

Write your review

Write your review

Lepu Medical - MemoPart VSD Occluder

Write your review